Product image of Movicolib (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350) supplied by GNH India

Movicolib

Active Ingredient:
Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350
Origin:
EU

Movicolib (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350, the active ingredient in Movicolib, is an osmotic laxative presented as a powder for oral use. It is used to relieve constipation by retaining water in the intestinal lumen, softening stool and facilitating bowel movements.

GNH India supplies Movicolib as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Norgine Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Movicolib is an osmotic laxative that acts on the gastrointestinal tract to treat various forms of constipation.
  • Constipation: softens stool and promotes regular bowel movements.
  • Chronic constipation: provides long‑term relief for patients with persistent constipation.
  • Bowel preparation before colonoscopy: clears the intestinal tract to allow clear visualization during endoscopic procedures.

How It Works

  • Macrogol 3350 creates an osmotic gradient within the intestinal lumen by binding water molecules. The retained water increases stool volume and softness, which stimulates peristalsis and accelerates transit, resulting in easier and more frequent bowel movements without being absorbed systemically.

Side Effects

Movicolib may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Abdominal bloating or distension.
  • Nausea or mild stomach discomfort.
  • Flatulence or gas.
  • Diarrhoea, especially with higher doses.
  • Thirst or increased fluid intake.
  • Electrolyte imbalance (mild).

Serious or Rare Side Effects

  • Severe dehydration.
  • Significant electrolyte disturbances (e.g., hypernatremia, hypokalemia).
  • Allergic reactions such as rash, itching, or swelling.
  • Persistent abdominal pain.
  • Signs of intestinal obstruction.
  • Unexplained weight loss.

Precautions & Warnings

  • Before using Movicolib, consider the following safety measures.
  • Renal impairment: monitor kidney function and fluid balance.
  • Electrolyte disorders: assess serum electrolytes, especially potassium and sodium.
  • Pregnancy and lactation: use only if clearly needed and prescribed.
  • Elderly patients: start with the lowest effective dose and watch for dehydration.
  • Concurrent laxative use: avoid combining with other osmotic or stimulant laxatives.
  • Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Movicolib can interact with other medicines, altering their absorption or electrolyte balance.

Major Interactions (Avoid)

  • Lithium: increased risk of lithium toxicity due to altered renal clearance.
  • Digoxin: potential for electrolyte shifts that may affect cardiac conduction.
  • Certain antibiotics (e.g., quinolones): reduced absorption when taken simultaneously.

Moderate Interactions (Monitor Closely)

  • Diuretics: monitor for additive effects on fluid and electrolyte status.
  • Antacids containing magnesium or aluminum: may affect stool consistency.
  • Antihypertensives: watch for changes in blood pressure due to fluid shifts.

Frequently Asked Questions

Movicolib is an oral osmotic laxative indicated for the relief of constipation, including chronic constipation, and for bowel preparation before colonoscopy. It works by drawing water into the intestinal lumen, softening stool and promoting regular bowel movements.

Macrogol 3350, the key ingredient in Movicolib, creates an osmotic gradient that retains water in the gut. The increased water content softens the stool, expands its volume, and stimulates peristalsis, which together facilitate easier and more frequent evacuation.

The appropriate dose of Movicolib is determined by the prescribing healthcare professional based on the patient’s condition, age, and response to therapy. Dosage may be adjusted to achieve the desired bowel movement frequency while minimizing side effects.

Safety data for Movicolib in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and only under medical supervision.

To order Movicolib, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives, Movicolib (PEG 3350) works osmotically, offering a gentler, non‑stimulatory approach that is less likely to cause cramping. It is often preferred for chronic use because it does not lead to dependence and has a favorable safety profile when used as directed.

Store Movicolib at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Movicolib is taken orally. The powder is typically dissolved in water or another suitable liquid, mixed thoroughly, and consumed as directed by the prescriber. It should be taken with adequate fluid intake to support its osmotic action.

Serious risks include severe dehydration, significant electrolyte disturbances such as hypernatremia or hypokalemia, and rare allergic reactions. Patients should be monitored for signs of these conditions, especially if they have renal impairment or are on interacting medications.

Movicolib should be avoided in individuals with known hypersensitivity to any of its components, in patients with intestinal obstruction, perforation, or severe inflammatory bowel disease, and in those with uncontrolled electrolyte imbalances unless medically supervised.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT